4//SEC Filing
Eide Langley P. 4
Accession 0001209191-18-047659
CIK 0001689923other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 6:08 PM ET
Size
18.1 KB
Accession
0001209191-18-047659
Insider Transaction Report
Form 4
Eide Langley P.
Chief Strategy Officer
Transactions
- Conversion
Class A Common Stock
2018-08-16+30,000→ 48,189 total - Exercise/Conversion
Class B Common Stock
2018-08-16+30,000→ 30,000 totalExercise: $0.00→ Class A Common Stock (30,000 underlying) - Conversion
Class B Common Stock
2018-08-16−30,000→ 0 totalExercise: $0.00→ Class A Common Stock (30,000 underlying) - Sale
Class A Common Stock
2018-08-16$53.93/sh−30,000$1,617,900→ 18,189 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-08-16−20,832→ 23,436 totalExercise: $4.34Exp: 2025-05-12→ Class B Common Stock (20,832 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2018-08-16−9,168→ 32,830 totalExercise: $12.30Exp: 2026-11-28→ Class B Common Stock (9,168 underlying)
Footnotes (6)
- [F1]Includes 18,189 shares subject to an award of restricted stock units ("RSUs"), of which 1/4th of the total RSUs will vest on January 1, 2019, and on each yearly anniversary thereafter, subject to the status of "Participant's Service" (as defined in the 2017 Equity Incentive Plan) through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.50 to $54.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F3]The stock option vested and became exercisable as to 1/4th of the shares subject to the option on April 23, 2016, and thereafter vested and shall continue to vest as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
- [F4]The stock option vested and became exercisable as to 1/4th of the shares subject to the option on November 29, 2017, and thereafter vests and shall continue to vest as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
- [F5]Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date.
- [F6]Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the earliest to occur of the following: (a) the date specified by a vote of the holders of 66 2/3% of the outstanding shares of Class B Common Stock, (b) March 23, 2027, and (c) the date the shares of Class B Common Stock cease to represent at least 10% of all outstanding shares of Common Stock. The shares of Class A Common Stock and Class B Common Stock have no expiration date.
Documents
Issuer
Alteryx, Inc.
CIK 0001689923
Entity typeother
Related Parties
1- filerCIK 0001715350
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 6:08 PM ET
- Size
- 18.1 KB